| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |